Expertise
Our Clinical Expertise
With over 3,000 clinical ophthalmology projects completed, our teams are not just experts — they’re THE experts.
Retina & Macular Diseases Glaucoma & Optic Neuropathies Cornea & Ocular Surface
Cataract & Refractive Conditions Inflammatory & Autoimmune
Services
Our Approach
We have the right people, processes and technology to streamline research and development and deliver the highest quality results.
Site Solutions Safety & Monitoring Data & Biostatistics Clinical Tools & Processes
Regulatory Approach Ora Endpoints & Technologies PRE-IND & Scientific Advisory Meetings
Why Ora
The Ora Way
As the trusted guide of ophthalmic innovators, we’re here to help navigate the complexities of ophthalmic product development together.
Our Global Reach The Blind Canvas Project Case Studies

Driving Success in Global Study Start-up
A Case Study in Myopia Progression Demonstrating Enrollment Success
View all Case Studies
Company
The Leadership Team
Ophthalmic innovators have trusted our guidance for over 50 years. We’re leading the way in global ophthalmic product development through precision, expertise, and innovation.
Employee Spotlight Careers Conference Schedule News & Press Releases
FEATURED NEWS
Ora appoints industry veteran Bill Sharbaugh as Chairman of the Board of Directors
Read more
EMPLOYEE SPOTLIGHT

Shea Berkowitz 
Associate Director, Clinical Operations
Resources

Ora Therapeutic Segment Booklet 2025 – French Translation

Published: August 2025

Additional Articles

Setting Eligibility Criteria

Setting Eligibility Criteria

Learn more about how inclusion and exclusion criteria can set the stage for study approval.

How Do You Qualify The Qualitative?

How Do You Qualify The Qualitative?

When it comes to scales, we should be asking the question: are we all on the same page? Is your 2+ redness the same as mine?

The Drug Development Path

The Drug Development Path

Gain insight on the different steps and phases of the clinical development journey.

Ora’s Ethos

Ora’s Ethos

Learn about Ora’s involvement in ophthalmic therapeutic development, which spans from preclinical research to clinical trials.